Sculptor Capital’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-763,420
Closed -$7.85M 773
2022
Q4
$7.85M Sell
763,420
-100,925
-12% -$1.03M 0.14% 179
2022
Q3
$8.7M Buy
864,345
+6,169
+0.7% +$62K 0.11% 241
2022
Q2
$8.6M Sell
858,176
-141,824
-14% -$1.42M 0.09% 277
2022
Q1
$10M Buy
1,000,000
+500,000
+100% +$4.97M 0.08% 253
2021
Q4
$4.95M Buy
+500,000
New +$4.94M 0.04% 378

Other funds holding IQMD

Sculptor Capital's IQMD Position: Q1 2023 in Review

Sculptor Capital sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 763,420 shares — an estimated $7.85M sold.

Sculptor Capital first reported a position in IQMD in Q4 2021 and held it in 5 quarters. The position peaked at $10M in Q1 2022. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

  • Sculptor Capital reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Sculptor Capital sold 763,420 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $7.85M.
  • Sculptor Capital first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 5 quarters.
  • Sculptor Capital's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $10M in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on Sculptor Capital's 13F filing for Q1 2023, filed 16 May 2023.